# Noninvasive Assessment of Metabolic Associated Fatty Liver Disease (MAFLD) in Chinese Population

> **NCT04551716** · — · COMPLETED · sponsor: **Chinese PLA General Hospital** · enrollment: 448 (actual)

## Conditions studied

- Metabolic-dysfunction-associated Fatty Liver Disease (MAFLD)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04551716
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-10
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-08-31
- **Target enrollment:** 448 (ACTUAL)
- **Last updated:** 2022-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04551716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04551716, "Noninvasive Assessment of Metabolic Associated Fatty Liver Disease (MAFLD) in Chinese Population". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04551716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*